Literature DB >> 6865916

Identification of 2-imidazolines as anti-sickling agents.

H Chang, S M Ewert, R L Nagel.   

Abstract

The drugs tolazoline, clonidine, lofexidine, and fenmetozole were found to inhibit the gelation of hemoglobin S in the order of increasing effectiveness. Only the latter, however, reduced the sickling of red cells significantly and normalized the oxygen affinity of SS blood at 5-10 mM concentrations. Since this level of drug is lower than those reported for many other anti-sickling agents to achieve comparable effects, the 2-imidazoline class of compounds may provide important clues for the development of therapy for sickle cell anemia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6865916

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  3 in total

1.  Imaging flow cytometry for automated detection of hypoxia-induced erythrocyte shape change in sickle cell disease.

Authors:  Eduard J van Beers; Leigh Samsel; Laurel Mendelsohn; Rehan Saiyed; Kleber Y Fertrin; Christine A Brantner; Mathew P Daniels; James Nichols; J Philip McCoy; Gregory J Kato
Journal:  Am J Hematol       Date:  2014-04-12       Impact factor: 10.047

2.  Visualizing red blood cell sickling and the effects of inhibition of sphingosine kinase 1 using soft X-ray tomography.

Authors:  Michele C Darrow; Yujin Zhang; Bertrand P Cinquin; Elizabeth A Smith; Rosanne Boudreau; Ryan H Rochat; Michael F Schmid; Yang Xia; Carolyn A Larabell; Wah Chiu
Journal:  J Cell Sci       Date:  2016-08-09       Impact factor: 5.285

3.  Sodium metabisulfite-induced polymerization of sickle cell hemoglobin incubated in the extracts of three medicinal plants (Anacardium occidentale, Psidium guajava, and Terminalia catappa).

Authors:  Paul Chidoka Chikezie
Journal:  Pharmacogn Mag       Date:  2011-04       Impact factor: 1.085

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.